Advanced wound care products — bioengineered skin substitutes, growth factor therapies, negative pressure wound therapy — represent an $18B market growing at 6% annually.
Market Opportunity
Advanced wound care products — bioengineered skin substitutes, growth factor therapies, negative pressure wound therapy — represent an $18B market growing at 6% annually. IKON Group Investments actively monitors this sector for compelling investment opportunities that meet our rigorous criteria for management quality, competitive positioning, and value creation potential.
Investment Framework
Our approach to evaluating investments in this sector leverages IKON Group’s deep domain expertise, extensive network of industry relationships, and disciplined analytical framework built on decades of investment experience.
Strategic Implications
For IKON Group’s existing portfolio, this sector creates strategic adjacencies, potential synergy opportunities, and valuable market intelligence that informs our broader investment strategy.